ADMA: an emerging cardiovascular risk factor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ADMA: an emerging cardiovascular risk factor

Published:2005-07 Issue:1_suppl Volume:10 Page:S1-S2
ISSN:1358-863X
Container-title:Vascular Medicine
language:en
Short-container-title:Vasc Med

Author:

Böger Rainer H¹,Cooke John P²,Vallance Patrick³

Affiliation:

1. Clinical Pharmacology Unit, Institute of Experimental and Clinical Pharmacology and Toxicology, University Hospital Hamburg-Eppendorf, Germany

2. Section of Vascular Medicine, Falk Cardiovascular Research Center, Stanford University School of Medicine, Stanford, CA, USA

3. Centre for Clinical Pharmacology, The British Heart Foundation Laboratories, University College London, UK

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/1358836X0501000101

Reference8 articles.

1. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

2. Endogenous Nitric Oxide Synthase Inhibitor

3. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

4. Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

5. Dimethylarginine Dimethylaminohydrolase Regulates Nitric Oxide Synthesis

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homoarginine and methylarginines independently predict long-term outcome in patients presenting with suspicion of venous thromboembolism;Scientific Reports;2021-05-05

2. The Second Life of Methylarginines as Cardiovascular Targets;International Journal of Molecular Sciences;2019-09-17

3. Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension;Terapevticheskii arkhiv;2019-09-15

4. Assessment of potential cardiovascular risk in trichloroethylene exposure by serum methylated arginine levels;International Journal of Environmental Health Research;2019-06-24

5. Nitric Oxide (Prong-2);Clinical Autonomic and Mitochondrial Disorders;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3